BE827255A - Nouveaux derives de l'amino-3 dihydrothiophenone-2 - Google Patents

Nouveaux derives de l'amino-3 dihydrothiophenone-2

Info

Publication number
BE827255A
BE827255A BE154829A BE154829A BE827255A BE 827255 A BE827255 A BE 827255A BE 154829 A BE154829 A BE 154829A BE 154829 A BE154829 A BE 154829A BE 827255 A BE827255 A BE 827255A
Authority
BE
Belgium
Prior art keywords
dihydrothiophenone
amino
new derivatives
derivatives
new
Prior art date
Application number
BE154829A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE827255A publication Critical patent/BE827255A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
BE154829A 1974-03-28 1975-03-27 Nouveaux derives de l'amino-3 dihydrothiophenone-2 BE827255A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7410913A FR2265355B1 (da) 1974-03-28 1974-03-28

Publications (1)

Publication Number Publication Date
BE827255A true BE827255A (fr) 1975-09-29

Family

ID=9136994

Family Applications (1)

Application Number Title Priority Date Filing Date
BE154829A BE827255A (fr) 1974-03-28 1975-03-27 Nouveaux derives de l'amino-3 dihydrothiophenone-2

Country Status (7)

Country Link
US (1) US4072703A (da)
JP (1) JPS5939425B2 (da)
BE (1) BE827255A (da)
CA (1) CA1058168A (da)
DE (1) DE2513842A1 (da)
FR (1) FR2265355B1 (da)
GB (1) GB1506934A (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105789A (en) * 1976-05-10 1978-08-08 E. R. Squibb & Sons, Inc. Carboxyalkylacylamino acids
US4269849A (en) * 1979-02-22 1981-05-26 Chevron Research Company Fungicidal 3-(N-cycloalkylcarbonyl-N-arylamino)-gamma-butyrolactones and gamma-butyrothiolactones
IT1134458B (it) * 1980-11-26 1986-08-13 Real Sas Di Alberto Reiner Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
FR2502153A1 (fr) * 1981-03-19 1982-09-24 Rech Pharmaceutiq Medicale Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant
IT1161218B (it) * 1983-03-23 1987-03-18 Yason Srl Derivato del tetraidrotiofenone attivo nelle affezioni broncopolmonari
US4595656A (en) * 1984-01-06 1986-06-17 Becton Dickinson & Company Coupling agents and products produced therefrom
IT1215238B (it) * 1985-02-22 1990-01-31 Chiesi Farma Spa Derivati di omocisteina tiolattone,loro procedimento di preparazione e formulazioni farmaceutiche
WO1991010421A1 (en) * 1990-01-16 1991-07-25 Reckitt & Colman Use of n-acyl derivatives of homocysteine to modify the structure of keratin and cosmetic compositions containing these derivatives
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
ES2061398B1 (es) * 1993-03-02 1996-02-16 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir del dl-homocistina por metodos electroquimicos.
US5508272A (en) * 1993-06-15 1996-04-16 Bristol-Myers Squibb Company Compounds containing a fused bicycle ring and processes therefor
EP0706393B1 (en) * 1993-07-02 1999-09-08 The University Of Nottingham Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
US5616775A (en) * 1994-05-05 1997-04-01 Bristol-Myers Squibb Co. Process for preparing homocystein analogs useful as intermediates for compounds containing a fused bicyclic ring
US8624063B2 (en) 2009-06-30 2014-01-07 Wisconsin Alumni Research Foundation Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing
WO2013037984A1 (en) * 2011-09-16 2013-03-21 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
ES2683860T3 (es) 2014-04-08 2018-09-28 Neurovive Pharmaceutical Ab Compuestos de succinato con permeabilidad celular novedosos
US10526278B2 (en) 2017-10-19 2020-01-07 Wisconsin Alumni Research Foundation Inhibitors of quorum sensing receptor LasR

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2935529A (en) * 1956-12-21 1960-05-03 Degussa Process for the production of homocysteine compounds
DE1199276B (de) * 1962-09-20 1965-08-26 Degussa Verfahren zur Herstellung von D, L-Homo-cysteinderivaten
FR2068398B2 (da) * 1969-10-07 1973-01-12 Rech Pharmac Scientif
FR2129877B1 (da) * 1971-03-18 1974-08-02 Fuveau Sa
DE2328391A1 (de) * 1972-06-19 1974-01-10 Degussa Trialkoxycinnamoylaminocarbonsaeuren

Also Published As

Publication number Publication date
DE2513842A1 (de) 1975-10-09
GB1506934A (en) 1978-04-12
JPS5939425B2 (ja) 1984-09-22
JPS50135025A (da) 1975-10-25
FR2265355A1 (da) 1975-10-24
FR2265355B1 (da) 1977-11-04
CA1058168A (en) 1979-07-10
US4072703A (en) 1978-02-07

Similar Documents

Publication Publication Date Title
FR2276043A1 (fr) Nouveaux derives de benzocycloamide
BE833580A (fr) Nouveaux derives d'arylamines soufrees
BE814790A (fr) Nouveaux derives d'arylthioalcanols
BE836528A (fr) Nouveaux derives d'acide 3-amino- indazolecarboxylique
BE827255A (fr) Nouveaux derives de l'amino-3 dihydrothiophenone-2
BE821406A (fr) Derives de 1
BE820789A (fr) Nouveaux derives de l'isoquinoleine
FR2298332A1 (fr) Nouveaux derives de 5-fluorouraciles
FR2316926A1 (fr) Nouveaux derives de bicycloheptenes
FR2298328A1 (fr) Nouveaux derives d'imidazole
FR2301253A1 (fr) Derives de la
BE829344A (fr) Preparation de l'alpha-6-desocy-5- hydroxytetracycline
BE848962A (fr) Nouveaux derives de l'indazole
BE835330A (fr) Purification de l'urokinase
RO66809A (ro) Diblu de spraituire
BE828549A (fr) Nouveaux derives d'alcanolamine
BE810748A (fr) Nouveaux derives de l'isoindoline
BE820479A (fr) Nouveaux derives du 2
FR2319605A1 (fr) Preparation de melanges d'alkylnaphtalenes
IT1060881B (it) Preparazione di 3 fenossibenzaldeidi
FR2275202A1 (fr) Derives tricycliques d'alcoylamines et preparation de ceux-ci
BE809762A (fr) Nouveaux derives de l'hydroxymethyl-2 oxadiazole-1
BE812134R (fr) Nouveaux derives de 1
BE795041A (fr) Nouveaux derives de l'amino-propane
BE821819A (fr) Nouveaux derives de substitution du 2

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BLUM JEAN

Effective date: 19850327